Impact of Alanyl-glutamine on Immune Function of Postoperative Non-small Cell Lung Cancer Patients
Daqian Sun
Abstract
Daqian Sun
Abstract
Objective To investigate the impact of the Alanyl-glutamine(Ala-Glu) injection on the post-operative immune function of patients with NSCLC.Methods Seventy patients undergoing NSCLC surgery in our hospital between February and June 2011 were randomly divided into an experimental group(n=35) and a control group(n=35) by random number table.All the patients were served with the same amount of food after surgery.Patients in the experimental group were given 0.5 g·kg-1·d-1 Ala-Glu injection during day 1~day 7 after surgery.The IgG,IgA,IgM,C3,C4,CD3+,CD4+,CD8+,and CD4+/CD8+ were observed on day 1 before surgery,and day 4 and 8 after surgery.Results The IgG,IgA,IgM and C4 of the control group,and the IgG,IgA,IgM,C3,and C4 of the experimental group were significantly different on day 1 before surgery,day 4 and day 8 after surgery(P0.05).The IgG,IgA,IgM,and C4 of both groups were significantly different on day 1 before surgery and day 4 after surgery(P0.05).The IgG,IgA,IgM,C3,and C4 on neither day 1 before surgery nor day 4 after surgery were significantly different between the two groups(P0.05).The IgA and C3 on day 8 were significantly different between the two groups(P0.05).The CD3+,CD4+,and CD8+ of the control group,and the CD4+ and CD8+ of the experimental group were significantly different on day 1 before surgery,day 4 and day 8 after surgery(P0.05).The CD3+ and CD4+ of the control group,and the CD8+ of the experimental group were significantly different on day 1 before surgery and day 4 after surgery(P0.05).The CD3+,CD4+,CD8+,and CD4+/CD8+ on neither day 1 before surgery nor day 4 after surgery were significantly different between the two groups(P0.05).The CD4+,CD8+,and CD4+/CD8+ on day 8 were significantly different between the two groups(P0.05).Conclusion The IgA,C3,CD4+,CD8+,and CD4+/CD8+ of the experimental group on day 8 after surgery were significantly higher than those of the control group.Therefore,the Ala-Glu injection can significantly improve the post-operative immune function in patients with NSCLC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the impact of the Alanyl-glutamine(Ala-Glu) injection on the post-operative immune function of patients with NSCLC.Methods Seventy patients undergoing NSCLC surgery in our hospital between February and June 2011 were randomly divided into an experimental group(n=35) and a control group(n=35) by random number table.All the patients were served with the same amount of food after surgery.Patients in the experimental group were given 0.5 g·kg-1·d-1 Ala-Glu injection during day 1~day 7 after surgery.The IgG,IgA,IgM,C3,C4,CD3+,CD4+,CD8+,and CD4+/CD8+ were observed on day 1 before surgery,and day 4 and 8 after surgery.Results The IgG,IgA,IgM and C4 of the control group,and the IgG,IgA,IgM,C3,and C4 of the experimental group were significantly different on day 1 before surgery,day 4 and day 8 after surgery(P0.05).The IgG,IgA,IgM,and C4 of both groups were significantly different on day 1 before surgery and day 4 after surgery(P0.05).The IgG,IgA,IgM,C3,and C4 on neither day 1 before surgery nor day 4 after surgery were significantly different between the two groups(P0.05).The IgA and C3 on day 8 were significantly different between the two groups(P0.05).The CD3+,CD4+,and CD8+ of the control group,and the CD4+ and CD8+ of the experimental group were significantly different on day 1 before surgery,day 4 and day 8 after surgery(P0.05).The CD3+ and CD4+ of the control group,and the CD8+ of the experimental group were significantly different on day 1 before surgery and day 4 after surgery(P0.05).The CD3+,CD4+,CD8+,and CD4+/CD8+ on neither day 1 before surgery nor day 4 after surgery were significantly different between the two groups(P0.05).The CD4+,CD8+,and CD4+/CD8+ on day 8 were significantly different between the two groups(P0.05).Conclusion The IgA,C3,CD4+,CD8+,and CD4+/CD8+ of the experimental group on day 8 after surgery were significantly higher than those of the control group.Therefore,the Ala-Glu injection can significantly improve the post-operative immune function in patients with NSCLC.
Key concepts: Medicine, CD8, Immune system, Lung cancer, Gastroenterology, Immunologic function, Lung cancer surgery, Glutamine